Vincent Xu

IM Resident @ UW Madison | Graduate of @GWSMHS | @StBonaventure alum | STL

[NEJM @NEJM]

Original Article: Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer (phase 3 RASolute 302 trial) https://t.co/y4G27hfORg

#ASCO26 | @ASCO

[Vincent Xu @VinceEXu]

Proud to be graduating from @GWSMHS and excited to begin my residency training at @uw_medicine! I owe it all to everyone who has supported me along the way.

[Vincent Xu @VinceEXu]

@RyanMAntar @GWSMHS Congratulations Dr. Antar! Excited for the next chapter

[Critical Care Reviews @CritCareReviews]

Our latest blog is out -

Faith, Evidence and the Stars:
The ANDROMEDA‑SHOCK‑2 Trial

https://t.co/Yu9qoJa9Gr

[Tom Powles @tompowles1]

1/2 KN905 Enfortumab Vedotin + Pembro continues to transform bladder cancer in spectacle fashion. In cisplatin ineligible operable disease it beats cystectomy with EFS HR 0.4, OS HR 0.5. pCR of 57% is much ⬆️ than anything before #ESMO25 pCR> 50% questions unselected surgery

[GU Oncology Now @GUOncologyNow]

🔬 We spoke with Drs. Michael Whalen and Vincent Xu of @GWCancer on their recent analysis of neoadjuvant chemotherapy utilization for UTUC and the differences between perioperative radical #nephroureterectomy and NAC.

📺 Watch part one of this interview: https://t.co/2fjmJvQZWq

[Vincent Xu @VinceEXu]

New publication in Clinical Genitourinary Cancer! Our team investigated the utilization of neoadjuvant chemotherapy in upper tract urothelial carcinoma.
https://t.co/VMaquvrHhu

[Vincent Xu @VinceEXu]

Had an amazing experience at #ASCO2024! So greatful to be able to present our research in Upper Tract Urothelial Cancer at the Medical Student Forum and learn about the latest developments in oncology!

Read our abstract here:
https://t.co/0R1MgabZ82

[Current Oncology @CurrentOncology]

📢A new study by @RyanMAntar et al. reveals significant economic disparities in the receipt of standard care treatments and worse survival outcomes for low income muscle-invasive bladder cancer patients.
Read more: https://t.co/3eykmpYzHU
#BladderCancer #HealthEquity

[Vincent Xu @VinceEXu]

I’m honored to receive the William Beaumont Research Award and present our findings at @GWSMHS Research Showcase! Thank you to my amazing team and @GWUrology for all their support.

[Vincent Xu @VinceEXu]

Excited to share the publication of our team's work in Urologic Oncology!

[Urologic Oncology @UrolOncol]

Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases https://t.co/PPda5cuO54